miR‑372‑3p promotes preeclampsia progression by regulating twist1

Li,Ziwei; Wang,Jie; Li,Dianting; Chen,Haiying; Meng,Tao

doi:10.3892/etm.2022.11659

miR‑372‑3p promotes preeclampsia progression by regulating twist1

Authors:
- Ziwei Li
- Jie Wang
- Dianting Li
- Haiying Chen
- Tao Meng
View Affiliations

Affiliations: Department of Obstetrics, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning 110001, P.R. China
Published online on: October 19, 2022 https://doi.org/10.3892/etm.2022.11659
Article Number: 723
Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Preeclampsia (PE) is a common pregnancy‑related disorder worldwide. PE is mainly characterized by the defective migration and invasion of trophoblast cells. MicroRNAs (miRs) have been reported to serve an important role in PE. The purpose of the study was to explore the pathogenesis and therapeutic targets of preeclampsia. In the present study, reverse transcription‑quantitative PCR analysis revealed that the expression levels of miR‑372‑3p were upregulated in placental tissues from patients with PE. Notably, the expression levels of miR‑372‑3p were significantly upregulated in patients with early‑onset PE compared with patients with late‑onset PE. Moreover, in vitro analysis using wound healing, Transwell and western blotting assays demonstrated that miR‑372‑3p overexpression inhibited the migration, invasion and epithelial‑mesenchymal transition (EMT) of HTR‑8/SVneo trophoblast cells, respectively. Bioinformatics analysis and a dual luciferase reporter assay revealed that miR‑372‑3p is sponged by twist family bHLH transcription factor 1 (twist1). Rescue experiments found that miR‑372‑3p overexpression suppressed trophoblast cell migration, invasion and EMT by downregulating the expression of twist1. In conclusion, the present study revealed that high level of miR‑372‑3p may act as a factor to cause PE and may also be a potential novel therapeutic target for PE.

View Figures

View References

1	No authors listed. Gestational hypertension and preeclampsia: ACOG practice bulletin, number 222. Obstet Gynecol. 135:e237–e260. 2020.PubMed/NCBI View Article : Google Scholar
2	Shen XY, Zheng LL, Huang J, Kong HF, Chang YJ, Wang F and Xin H: CircTRNC18 inhibits trophoblast cell migration and epithelial-mesenchymal transition by regulating miR-762/Grhl2 pathway in pre-eclampsia. RNA Biol. 16:1565–1573. 2019.PubMed/NCBI View Article : Google Scholar
3	E Davies J, Pollheimer J, Yong HE, Kokkinos MI, Kalionis B, Knofler M and Murthi P: Epithelial-mesenchymal transition during extravillous trophoblast differentiation. Cell Adh Migr. 10:310–321. 2016.PubMed/NCBI View Article : Google Scholar
4	DaSilva-Arnold SC, Zamudio S, Al-Khan A, Alvarez-Perez J, Mannion C, Koenig C, Luke D, Perez AM, Petroff M, Alvarez M, et al: Human trophoblast epithelial-mesenchymal transition in abnormally invasive placenta. Biol Reprod. 99:409–421. 2018.PubMed/NCBI View Article : Google Scholar
5	Moldovan L, Batte KE, Trgovcich J, Wisler J, Marsh CB and Piper M: Methodological challenges in utilizing miRNAs as circulating biomarkers. J Cell Mol Med. 18:371–390. 2014.PubMed/NCBI View Article : Google Scholar
6	Cai Z, Li J, Zhuang Q, Zhang X, Yuan A, Shen L, Kang K, Qu B, Tang Y, Pu J, et al: MiR-125a-5p ameliorates monocrotaline-induced pulmonary arterial hypertension by targeting the TGF-β1 and IL-6/STAT3 signaling pathways. Exp Mol Med. 50:1–11. 2018.PubMed/NCBI View Article : Google Scholar
7	Shi J, Zhang Y, Jin N, Li Y, Wu S and Xu L: MicroRNA-221-3p plays an oncogenic role in gastric carcinoma by inhibiting PTEN expression. Oncol Res. 25:523–536. 2017.PubMed/NCBI View Article : Google Scholar
8	Peng H, Pan X, Su Q, Zhu LS and Ma GD: MiR-372-3p promotes tumor progression by targeting LATS2 in colorectal cancer. Eur Rev Med Pharmacol Sci. 23:8332–8344. 2019.PubMed/NCBI View Article : Google Scholar
9	Chen DB and Wang W: Human placental microRNAs and preeclampsia. Biol Reprod. 88(130)2013.PubMed/NCBI View Article : Google Scholar
10	Lv Y, Lu X, Li C, Fan Y, Ji X, Long W, Meng L, Wu L, Wang L, Lv M and Ding H: miR-145-5p promotes trophoblast cell growth and invasion by targeting FLT1. Life Sci. 239(117008)2019.PubMed/NCBI View Article : Google Scholar
11	Brkić J, Dunk C, O'Brien J, Fu G, Nadeem L, Wang YL, Rosman D, Salem M, Shynlova O, Yougbaré I, et al: MicroRNA-218-5p promotes endovascular trophoblast differentiation and spiral artery remodeling. Mol Ther. 26:2189–2205. 2018.PubMed/NCBI View Article : Google Scholar
12	Yang Y, Li H, Ma Y, Zhu X, Zhang S and Li J: MiR-221-3p is down-regulated in preeclampsia and affects trophoblast growth, invasion and migration partly via targeting thrombospondin 2. Biomed Pharmacother. 109:127–134. 2019.PubMed/NCBI View Article : Google Scholar
13	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar
14	Tayyar AT, Karakus R, Eraslan Sahin M, Topbas NF, Sahin E, Karakus S, Yalcin ET and Tayyar A: Wnt signaling pathway in early- and late-onset preeclampsia: Evaluation with Dickkopf-1 and R-Spondin-3 glycoproteins. Arch Gynecol Obstet. 299:1551–1556. 2019.PubMed/NCBI View Article : Google Scholar
15	von Dadelszen P, Magee LA and Roberts JM: Subclassification of preeclampsia. Hypertens Pregnancy. 22:143–148. 2003.PubMed/NCBI View Article : Google Scholar
16	Herzog EM, Eggink AJ, Reijnierse A, Kerkhof MA, de Krijger RR, Roks AJ, Reiss IK, Nigg AL, Eilers PH, Steegers EA, et al: Impact of early- and late-onset preeclampsia on features of placental and newborn vascular health. Placenta. 49:72–79. 2017.PubMed/NCBI View Article : Google Scholar
17	Cim N, Kurdoglu M, Ege S, Yoruk I, Yaman G and Yildizhan R: An analysis on the roles of angiogenesis-related factors including serum vitamin D, soluble endoglin (sEng), soluble fms-like tyrosine kinase 1 (sFlt1), and vascular endothelial growth factor (VEGF) in the diagnosis and severity of late-onset preeclampsia. J Matern Fetal Neonatal Med. 30:1602–1607. 2017.PubMed/NCBI View Article : Google Scholar
18	Karreth FA and Pandolfi PP: ceRNA cross-talk in cancer: When ce-bling rivalries go awry. Cancer Discov. 3:1113–1121. 2013.PubMed/NCBI View Article : Google Scholar
19	Yang R, Xing L, Zheng X, Sun Y, Wang X and Chen J: The circRNA circAGFG1 acts as a sponge of miR-195-5p to promote triple-negative breast cancer progression through regulating CCNE1 expression. Mol Cancer. 18(4)2019.PubMed/NCBI View Article : Google Scholar
20	Tay Y, Rinn J and Pandolfi PP: The multilayered complexity of ceRNA crosstalk and competition. Nature. 505:344–352. 2014.PubMed/NCBI View Article : Google Scholar
21	Kalluri R and Weinberg RA: The basics of epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428. 2009.PubMed/NCBI View Article : Google Scholar
22	Beermann J, Piccoli MT, Viereck J and Thum T: Non-coding RNAs in development and disease: Background, mechanisms, and therapeutic approaches. Physiol Rev. 96:1297–1325. 2016.PubMed/NCBI View Article : Google Scholar
23	Lee CT, Risom T and Strauss WM: Evolutionary conservation of microRNA regulatory circuits: An examination of microRNA gene complexity and conserved microRNA-target interactions through metazoan phylogeny. DNA Cell Biol. 26:209–218. 2007.PubMed/NCBI View Article : Google Scholar
24	Gantier MP, McCoy CE, Rusinova I, Saulep D, Wang D, Xu D, Irving AT, Behlke MA, Hertzog PJ, Mackay F and Williams BR: Analysis of microRNA turnover in mammalian cells following Dicer1 ablation. Nucleic Acids Res. 39:5692–5703. 2011.PubMed/NCBI View Article : Google Scholar
25	Sayed AS, Xia K, Salma U, Yang T and Peng J: Diagnosis, prognosis and therapeutic role of circulating miRNAs in cardiovascular diseases. Heart Lung Circ. 23:503–510. 2014.PubMed/NCBI View Article : Google Scholar
26	Sur S, Steele R, Shi X and Ray RB: miRNA-29b inhibits prostate tumor growth and induces apoptosis by increasing bim expression. Cells. 8(1455)2019.PubMed/NCBI View Article : Google Scholar
27	Ghafouri-Fard S, Shoorei H and Taheri M: miRNA profile in ovarian cancer. Exp Mol Pathol. 113(104381)2020.PubMed/NCBI View Article : Google Scholar
28	Hansen TB, Jensen TI, Clausen BH, Bramsen JB, Finsen B, Damgaard CK and Kjems J: Natural RNA circles function as efficient microRNA sponges. Nature. 495:384–388. 2013.PubMed/NCBI View Article : Google Scholar
29	Hromadnikova I, Kotlabova K, Ivankova K, Vedmetskaya Y and Krofta L: Profiling of cardiovascular and cerebrovascular disease associated microRNA expression in umbilical cord blood in gestational hypertension, preeclampsia and fetal growth restriction. Int J Cardiol. 249:402–409. 2017.PubMed/NCBI View Article : Google Scholar
30	Zhao G, Zhou X, Chen S, Miao H, Fan H, Wang Z, Hu Y and Hou Y: Differential expression of microRNAs in decidua-derived mesenchymal stem cells from patients with pre-eclampsia. J Biomed Sci. 21(81)2014.PubMed/NCBI View Article : Google Scholar
31	Zhou C, Zou QY, Li H, Wang RF, Liu AX, Magness RR and Zheng J: Preeclampsia downregulates MicroRNAs in fetal endothelial cells: Roles of miR-29a/c-3p in endothelial function. J Clin Endocrinol Metab. 102:3470–3479. 2017.PubMed/NCBI View Article : Google Scholar
32	Wang Q, Liu S, Zhao X, Wang Y, Tian D and Jiang W: MiR-372-3p promotes cell growth and metastasis by targeting FGF9 in lung squamous cell carcinoma. Cancer Med. 6:1323–1330. 2017.PubMed/NCBI View Article : Google Scholar
33	Li Y, Liu JJ, Zhou JH, Chen R and Cen CQ: LncRNA HULC induces the progression of osteosarcoma by regulating the miR-372-3p/HMGB1 signalling axis. Mol Med. 26(26)2020.PubMed/NCBI View Article : Google Scholar
34	Fan J, Zhang J, Huang S and Li P: lncRNA OSER1-AS1 acts as a ceRNA to promote tumorigenesis in hepatocellular carcinoma by regulating miR-372-3p/Rab23 axis. Biochem Biophys Res Commun. 521:196–203. 2020.PubMed/NCBI View Article : Google Scholar
35	Soliman MH, Ragheb MA, Elzayat EM, Mohamed MS, El-Ekiaby N, Abdelaziz AI and Abdel-Wahab AA: MicroRNA-372-3p predicts response of TACE patients treated with doxorubicin and enhances chemosensitivity in hepatocellular carcinoma. Anticancer Agents Med Chem. 21:246–253. 2021.PubMed/NCBI View Article : Google Scholar
36	Fan X, Huang X, Li Z and Ma X: MicroRNA-372-3p promotes the epithelial-mesenchymal transition in breast carcinoma by activating the Wnt pathway. J BUON. 23:1309–1315. 2018.PubMed/NCBI